ICICI Prudential Nifty Pharma Index Fund · Regular · Growth
NAV
₹18.2728
as of 16 Jun 2026
Expense Ratio
1.02%
AUM
₹97 Cr
Lumpsum returns (CAGR)
- 1Y
- +9.25%
- 3Y
- +21.42%
- 5Y
- —
- Since Inception
- +18.77%
SIP returns (XIRR)
- 1Y
- +14.51%
- 3Y
- +13.60%
- 5Y
- —
- Since Inception
- +16.00%
SIP since inception — what ₹100/month became
Real NAV backtest from day one
₹4,200
Invested
₹5,527
Value today
16.3%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹1,839
Value today
19.1%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹10,98,070
Value today
-0.5%
vs lumpsum
Direct lumpsum would have beaten STP by 0.5% — but STP reduced timing risk
Model your own STP with real NAVRisk Metrics
Trailing 1 year, annualised-0.04
Sharpe Ratio
—
Alpha
—
Beta
-0.04
Sortino
16.13%
Std Dev
-15.75%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Apr 2026Each sector links to the mutual funds most exposed to it.
Thinking about ICICI Prudential Nifty Pharma Index Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Investment Objective
ICICI Prudential Nifty Pharma Index Fund · Regular · Growth is a passively managed fund that tracks a specific market index, aiming to replicate its returns with minimal tracking error. Index funds offer low-cost, diversified exposure to the market with full transparency of holdings.
About This Fund
ICICI Prudential Nifty Pharma Index Fund · Regular · Growth is a Index Fund mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 3 years. It manages assets worth ₹96.8 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty Pharma TRI. The current expense ratio is 1.02%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •Cost-conscious investors who prefer passive investing with low expense ratios
- •SIP investors who can benefit from rupee cost averaging during market fluctuations